Host–Guest Interaction Study of Olmesartan Medoxomil with β-Cyclodextrin Derivatives
Olmesartan medoxomil (OLM) is a selective angiotensin II receptor antagonist used in the treatment of hypertension. Its therapeutic potential is limited by its poor water solubility, leading to poor bioavailability. Encapsulation of the drug substance by two methylated cyclodextrins, namely randomly...
| Published in: | Molecules |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-05-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/29/10/2209 |
